CN105497816A - 一种治疗动脉粥样硬化的中药制剂及其制备方法 - Google Patents
一种治疗动脉粥样硬化的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN105497816A CN105497816A CN201610052679.8A CN201610052679A CN105497816A CN 105497816 A CN105497816 A CN 105497816A CN 201610052679 A CN201610052679 A CN 201610052679A CN 105497816 A CN105497816 A CN 105497816A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- preparation
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 238000002360 preparation method Methods 0.000 title claims abstract description 62
- 201000001320 Atherosclerosis Diseases 0.000 title abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 44
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 230000003143 atherosclerotic effect Effects 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 241000628997 Flos Species 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 238000000108 ultra-filtration Methods 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 241000237636 Pheretima Species 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 10
- 241001649190 Campsis Species 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 5
- 238000009924 canning Methods 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 230000008719 thickening Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- -1 sublimed preparation Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000013618 particulate matter Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 6
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241000109329 Rosa xanthina Species 0.000 abstract 1
- 235000004789 Rosa xanthina Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000364 effect on atherosclerosis Effects 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 89
- 210000004369 blood Anatomy 0.000 description 88
- 210000004185 liver Anatomy 0.000 description 55
- 208000002193 Pain Diseases 0.000 description 42
- 239000000796 flavoring agent Substances 0.000 description 40
- 235000019634 flavors Nutrition 0.000 description 40
- 230000036407 pain Effects 0.000 description 40
- 235000009508 confectionery Nutrition 0.000 description 38
- 241000411851 herbal medicine Species 0.000 description 38
- 210000000952 spleen Anatomy 0.000 description 38
- 230000006870 function Effects 0.000 description 37
- 210000004072 lung Anatomy 0.000 description 33
- 239000002398 materia medica Substances 0.000 description 32
- 210000002216 heart Anatomy 0.000 description 31
- 231100000252 nontoxic Toxicity 0.000 description 31
- 230000003000 nontoxic effect Effects 0.000 description 31
- 210000003734 kidney Anatomy 0.000 description 25
- 210000002784 stomach Anatomy 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 20
- 208000006820 Arthralgia Diseases 0.000 description 19
- 206010011224 Cough Diseases 0.000 description 19
- 230000001717 pathogenic effect Effects 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 18
- 208000001848 dysentery Diseases 0.000 description 18
- 208000026435 phlegm Diseases 0.000 description 18
- 235000005911 diet Nutrition 0.000 description 17
- 208000002173 dizziness Diseases 0.000 description 16
- 206010047700 Vomiting Diseases 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 15
- 244000052769 pathogen Species 0.000 description 15
- 230000008961 swelling Effects 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 206010042674 Swelling Diseases 0.000 description 14
- 210000001015 abdomen Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 206010019233 Headaches Diseases 0.000 description 13
- 210000002683 foot Anatomy 0.000 description 13
- 231100000869 headache Toxicity 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 12
- 210000000038 chest Anatomy 0.000 description 12
- 210000000232 gallbladder Anatomy 0.000 description 12
- 230000008673 vomiting Effects 0.000 description 12
- 208000004998 Abdominal Pain Diseases 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 206010020772 Hypertension Diseases 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- 210000003932 urinary bladder Anatomy 0.000 description 11
- 208000019255 Menstrual disease Diseases 0.000 description 10
- 239000003172 expectorant agent Substances 0.000 description 10
- 230000003419 expectorant effect Effects 0.000 description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 10
- 239000002574 poison Substances 0.000 description 10
- 206010042772 syncope Diseases 0.000 description 10
- 230000035922 thirst Effects 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 9
- 230000000378 dietary effect Effects 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000002411 adverse Effects 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010000077 Abdominal mass Diseases 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 7
- 206010040943 Skin Ulcer Diseases 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 231100000019 skin ulcer Toxicity 0.000 description 7
- 206010002383 Angina Pectoris Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010011878 Deafness Diseases 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010038743 Restlessness Diseases 0.000 description 6
- 208000028659 discharge Diseases 0.000 description 6
- 206010015037 epilepsy Diseases 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 201000004792 malaria Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000001431 Psychomotor Agitation Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000024780 Urticaria Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 210000003423 ankle Anatomy 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 201000003453 lung abscess Diseases 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 208000004396 mastitis Diseases 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 4
- 235000017491 Bambusa tulda Nutrition 0.000 description 4
- 241001330002 Bambuseae Species 0.000 description 4
- 241000208365 Celastraceae Species 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 4
- 206010067171 Regurgitation Diseases 0.000 description 4
- 235000000336 Solanum dulcamara Nutrition 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 239000011425 bamboo Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000019902 chronic diarrheal disease Diseases 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 231100000895 deafness Toxicity 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 208000016354 hearing loss disease Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000001617 migratory effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000010349 pulsation Effects 0.000 description 4
- 230000004206 stomach function Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010023644 Lacrimation increased Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000003443 Unconsciousness Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000004317 lacrimation Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 208000004434 Calcinosis Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 208000027753 pain disease Diseases 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001124144 Dermaptera Species 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000008445 altitude sickness Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 238000013176 antiplatelet therapy Methods 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 229960002297 fenofibrate Drugs 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
- 229960001381 glipizide Drugs 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000004873 systolic arterial blood pressure Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中医药领域,尤其涉及一种治疗动脉粥样硬化的中药制剂。由绞股蓝、甘草、茯苓、枸杞、益母草、丹参、川穹、酸枣仁、泽泻、决明子、桔梗、薄荷、五味子、黄连、黄芪、夏枯草、鱼腥草、三七、瓜蒌、桂枝、白芍、车前子、钩藤、天麻、玫瑰花、柴胡、姜黄等组成。本发明相对于现有技术具有疗效好、成本低、局限性小、无不良反应等优点。本发明各原料有效成份相互影响、协同作用,对动脉粥样硬化有很好的治疗效果。而且本发明中药制备方法简单、配伍严谨、药性平和、安全无副作用、成本低廉,适宜各类人群服用,便于在临床上大面积推广应用。
Description
技术领域
本发明属于中药学技术领域,具体涉及一种治疗动脉粥样硬化的中药制剂及其制备方法。
背景技术
动脉粥样硬化是一组动脉硬化的血管病中常见的最重要的一种,其特点是受累动脉病变从内膜开始。一般先有脂质和复合糖类积聚、出血及血栓形成,纤维组织增生及钙质沉着,并有动脉中层的逐渐蜕变和钙化,病变常累及弹性及大中等肌性动脉,一旦发展到足以阻塞动脉腔,则该动脉所供应的组织或器官将缺血或坏死。由于在动脉内膜积聚的脂质外观呈黄色粥样,因此称为动脉粥样硬化。
动脉粥样硬化就是动脉壁上沉积了一层像小米粥样的脂类,使动脉弹性减低、管腔变窄的病变。高血压是促进动脉粥样硬化发生、发展的重要因子,而动脉因粥样硬化所致的狭窄又可引起继发性高血压。因此二者之间互相影响,互相促进,形影不离。高血压促进动脉粥样硬化,多发生于大、中动脉,包括心脏的冠状动脉、头部的脑动脉等这些要塞通道。高血压致使血液冲击血管内膜,导致管壁增厚、管腔变细。管壁内膜受损后易为胆固醇、脂质沉积,加重了动脉粥样斑块的形成。因此,高血压是动脉粥样硬化的危险因子。
动脉粥样硬化是动脉硬化的一种,大、中动脉内膜出现含胆固醇、类脂肪等的黄色物质,多由脂肪代谢紊乱,神经血管功能失调引起。常导致血栓形成、供血障碍等。也叫粥样硬化。
动脉粥样硬化的治疗常采用:(1)一般治疗:合理饮食:饮食总热量不应过高防止超重;坚持适量的体力活动;合理安排工作及生活;提倡不吸烟,可饮少量酒等;(2)控制易患因素:如患有糖尿病、应及时控制血糖,包括饮食控制。II型糖尿病的降糖药物应以不引起高胰岛素血症为宜;如有高血压则应给降压药,使血压降至适当水平,如有血胆固醇增高,则应控制高胆固醇适当给予降脂药物。(3)降血脂药物治疗:1、他汀类2、消胆胺、3、烟酸。4、不饱和脂肪酸。5、藻酸双酯钠。(4)抗血小板药物治疗:1、阿斯匹林。2、潘生丁等。西药治疗存在副作用大等缺点,而中医药在抑制动脉粥样硬化进程方面具有独特的优势,值得推广应用。
经过大量临床实践及查阅相关文献,发明人认为心、肺、脾、肾脏虚损以及肝失疏泄是AS发生的根本,痰浊、血瘀、热毒是动脉粥样硬化的关键病理因素。动脉粥样硬化的发生、发展是在脏腑虚损的基础上,痰浊、瘀血、热毒内生,凝滞血脉,损伤脉络,久致脉道枯涩,血脉失柔,甚则脉管狭窄,闭塞不通。因此,可以说邪留血脉,脉络损伤,脉道枯涩,血脉失柔是动脉粥样硬化的病机关键。在心肺脾肾虚的基础上,痰浊内盛、瘀血内停是动脉粥样硬化的潜在发病因素,痰湿留聚血脉,瘀血内生,脉络损伤,动脉粥样硬化病理过程随之启动。痰湿浊瘀日久化热毒,复又因实致虚,虚损不断加重。随着病变进一步发展,痰瘀交结,脉络受阻明显,脉道枯涩,脉管狭窄甚则闭塞不通是动脉粥样硬化的最严重阶段。
发明内容
为了克服现有技术中的不足,本发明提供一种治疗动脉粥样硬化的中药制剂,具有显著疗效。
为了解决上述技术问题,本发明采用的技术方案如下:一种治疗动脉粥样硬化的中药制剂,由以下各组分组成:
绞股蓝1-30份、甘草1-30份、茯苓1-30份、枸杞1-30份、益母草1-30份、丹参1-30份、川穹1-30份、酸枣仁1-30份、泽泻1-30份、决明子1-30份、桔梗1-30份、薄荷1-30份、五味子1-30份、黄连1-30份、黄芪1-30份、夏枯草1-30份、鱼腥草1-30份、三七1-30份、瓜蒌1-30份、桂枝1-30份、白芍1-30份、车前子1-30份、钩藤1-30份、天麻1-30份、玫瑰花1-30份、柴胡1-30份、姜黄1-30份、薤白1-30份、熟地黄1-30份、地龙1-30份、鸡血藤1-30份、桃仁1-30份、徐长卿1-30份、红景天1-30份、葛根1-30份、石菖蒲1-30份、半夏1-30份、金银花1-30份、凌霄花1-30份、白薇1-30份。
所述治疗动脉粥样硬化的中药组合物,其所述中药制剂中各种原料药的重量份数可以优选为:绞股蓝1-20份、甘草1-20份、茯苓1-20份、枸杞1-20份、益母草1-20份、丹参1-20份、川穹1-20份、酸枣仁1-20份、泽泻1-20份、决明子1-20份、桔梗1-20份、薄荷1-20份、五味子1-20份、黄连1-20份、黄芪1-20份、夏枯草1-20份、鱼腥草1-20份、三七1-20份、瓜蒌1-20份、桂枝1-20份、白芍1-20份、车前子1-20份、钩藤1-20份、天麻1-20份、玫瑰花1-20份、柴胡1-20份、姜黄1-20份、薤白1-20份、熟地黄1-20份、地龙1-20份、鸡血藤1-20份、桃仁1-20份、徐长卿1-20份、红景天1-20份、葛根1-20份、石菖蒲1-20份、半夏1-20份、金银花1-20份、凌霄花1-20份、白薇1-20份。
所述治疗动脉粥样硬化的中药组合物,其所述中药制剂中各种原料药的重量份数还可以优选为:绞股蓝1-10份、甘草1-10份、茯苓1-10份、枸杞1-10份、益母草1-10份、丹参1-10份、川穹1-10份、酸枣仁1-10份、泽泻1-10份、决明子1-10份、桔梗1-10份、薄荷1-10份、五味子1-10份、黄连1-10份、黄芪1-10份、夏枯草1-10份、鱼腥草1-10份、三七1-10份、瓜蒌1-10份、桂枝1-10份、白芍1-10份、车前子1-10份、钩藤1-10份、天麻1-10份、玫瑰花1-10份、柴胡1-10份、姜黄1-10份、薤白1-10份、熟地黄1-10份、地龙1-10份、鸡血藤1-10份、桃仁1-10份、徐长卿1-10份、红景天1-10份、葛根1-10份、石菖蒲1-10份、半夏1-10份、金银花1-10份、凌霄花1-10份、白薇1-10份。
所述治疗动脉粥样硬化的中药组合物,其所述中药制剂的剂型可以为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、蜜丸剂、散剂、丹剂、溶液剂、注射剂、栓剂、硬膏剂或糖浆剂。
为解决上述技术问题,本发明还提供治疗动脉粥样硬化的中药组合物的制备方法,所述制剂剂型为口服液剂,其制备方法的包括:
a、取原料放入乙醇中浸泡,热提取2次,成膏状,为组分1;
b、药渣水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状浓缩成糊状,灭菌,加入糊精,然后真空冷冻密封。
所述步骤a中,取原料加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-180目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分1。
所述步骤b中,将乙醇提取过的药渣放入10倍量水中,加热回流提取2次,每次提取时间为1~2小时,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分2。
所述步骤c中,将上述两种组分膏状浓缩成糊状,浓缩液用CO60灭菌,辐照剂量8k,加入糊精,然后真空罐装密封即得,使用时直接饮用。
为解决上述技术问题,本发明也提供治疗动脉粥样硬化的中药组合物的制备方法,所述制剂剂型为胶囊剂,其制备方法的包括:
a.将所述原料放入粉碎机粉碎后过筛;
b.将过筛后剩下的颗粒物放入乙醇中加热回流提取2次;
c.再取上述乙醇提取后的药渣,加水加热回流提取1次;
d.将上述两种提取液合并,减压回收乙醇并喷雾干燥,得药粉;混合过筛得到的药粉装入胶囊制为胶囊剂。
为解决上述技术问题,本发明也提供治疗动脉粥样硬化的中药组合物的制备方法,所述内服药物的剂型为丸剂,其制备步骤包括:
a.将所述原料药混合,切碎,过120目筛,得细药粉备用;
b.将未过筛的粗粉浸泡乙醇中提取2次;
c.再取上述步骤提取后的药渣,加水加热回流提取2次;
d.将上述两种提取液合并,减压回收乙醇成浸膏,与a步骤得到细药粉合并加入蜂蜜搓成丸剂。
所述治疗动脉粥样硬化的中药组合物,其所述中药的使用方法为,本发明做煎汤剂服用时,每日1剂,水煎分两次服,每10天为一疗程;胶囊剂、片剂、丸剂使用时,每次1片、1粒或1丸,每日三次,每7日为一疗程。
本发明相对于现有技术具有疗效好、成本低、局限性小、无不良反应等优点。本发明各原料有效成份相互影响、协同作用,对动脉粥样硬化患者有很好的治疗效果。而且本发明中药制备方法简单、配伍严谨、药性平和、安全无副作用、成本低廉,适宜各类人群服用,便于在临床上大面积推广应用。
具体实施方式
中医中药在治疗动脉粥样硬化方面有其自身独特的优势,中药能够多靶点、全方位地稳定斑块,降低血脂、保护受损的内皮细胞、抑制炎症状态和发挥抗凝作用,口服药物治疗无副作用,而且有些中药能够通过其软坚散结的作用促使斑块面积的减小或消退。随着社会的发展,生活节奏的加快,饮食结构的变化,肥胖、高血压、高脂血症、糖尿病等疾病的发生率逐渐上升,动脉硬化症的发生率亦明显升高。动脉硬化问题亟待解决。但现有的中药治疗动脉硬化的药物一般原料配方较多,制备工艺复杂,质量控制困难,服用量较多,疗效不满意等。
绞股蓝:性味:味苦;微甘;性凉。归经:归肺;脾;肾经。功能主治:清热;补虚;解毒。主体虚乏力;虚劳失精;白细胞减少症;高脂血症;病毒性肝炎;慢性胃肠炎;慢性气管炎。
甘草:性味:甘,平。归经:归心、肺、脾、胃经。功能主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
茯苓:性味:甘淡,平。①《本经》:″味甘,平。"②《医学启源》:"《主治秘诀》云,性温,味淡。"归经:入心、脾、肺经。①《汤液本草》:"入手大阴,足大阳、少阳经。"②《本草蒙筌》:″入膀胱、肾、肺。"③《雷公炮制药性解》:"入肺、脾、小肠三经。"④《本草经疏》:"入手足少阴,手太阳,足太阴、阳明经。"功能主治:渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。
枸杞:性味:甘,平。①《别录》:"微寒,无毒。″②《药性论》:″味甘,平。"③《食疗本草》:"寒,无毒。"归经:入肝、肾经。①《本草汇言》:"入足少阴、足厥阴经。"②《本草经解》:″入足少阴肾经、手少阴心经。"③《要药分剂》:"入肝、胃二经,兼入肺经。"功能主治:滋肾,润肺,补肝,明目。治肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精。①陶弘景:″补益精气,强盛阴道。″②《药性论》:″能补益精诸不足,易颜色,变白,明目,安神。③《食疗本草》:″坚筋耐老,除风,补益筋骨,能益人,去虚劳。"④王好古:"主心病嗌干,心痛,渴而引饮,肾病消中。"⑤《纲目》:"滋肾,润肺,明目。″
益母草:性味:辛苦,凉。①《本草拾遗》:″寒。″②《本草蒙筌》:″味辛甘,气微温,无毒。"③《纲目》:″味辛微苦,无毒。"④《本草正》:"味微苦、微辛。微寒,性滑。″归经:入心包、肝经。①《本草汇言》:"手、足厥阴经。″②《药品化义》:"入肝、脾、包络三经。″③《本草再新》:"入心、脾、肾三经。″功能主治:活血,祛瘀,调经,消水。治月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血,泻血,痈肿疮疡。①《本经》:"主瘾疹痒。″②《唐本草》:"敷丁肿,服汁使丁肿毒内消;又下子死腹中,主产后胀闷;诸杂毒肿,丹游等肿;取汁如豆滴耳中,主聤耳;中虺蛇毒,敷之。"③《本草拾遗》:″捣苗,敷乳痈恶肿痛者;又捣苗绞汁服,主浮肿下水,兼恶毒肿。″④《本草衍义》:″治产前产后诸疾,行血养血;难产作膏服。″
丹参:性味:苦,微温。①《本经》;"味苦,微寒,无毒。″②《吴普本草》:"岐伯:咸。″③李当之《药录》:″大寒。″④《本草经疏》:"味苦,平,微温。″归经:入心、肝经。①《纲目》:″手少阴、厥阴血分药。"②《本草经疏》:″入手足少阴、足厥阴经。″③《本草正》:″心、脾、肝、肾血分之药。"功能主治:活血祛瘀,安神宁心,排脓,止痛。治心绞痛,月经不调,痛经,经闭,血崩带下,症瘕,积聚,瘀血腹痛,骨节疼痛,惊悸不眠,恶疮肿毒。①《本经》:″主心腹邪气,肠鸣幽幽如走水,寒热积聚;破症除瘕,止烦满,益气。″②《吴普本草》:"治心腹痛。"③《别录》:"养血,去心腹痼疾结气,腰脊强,脚痹;除风邪留热,久服利人。"④陶弘景:"渍酒饮之,疗风痹。"
川穹:性味:辛,温。①《本经》:″味辛,温。″②《吴普本草》:"黄帝、岐伯、雷公:辛,无毒,香。扁鹊:酸,无毒。李氏:生温,熟寒。″③《唐本草》:″味苦辛。″④《本草正》:"味辛微甘,气温。″归经:入肝、胆经。①《汤液本草》:″入手足厥阴经、少阳经。″②《药品化义》:″入肝、脾、三焦三经。"功能主治:行气开郁,法风燥湿,活血止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。①《本经》:″主中风入脑头痛,寒痹,筋挛缓急,金创,妇人血闭无子。"②《别录》:″除脑中冷动,面上游风去来,目泪出,多涕唾,忽忽如醉,诸寒冷气,心腹坚痛,中恶,卒急肿痛,胁风痛,温中内寒。″
酸枣仁:性味:甘,平。①《本经》:″味酸,平。″②《别录》:″无毒。"③《本草衍义》:"微温。"④《饮膳正要》:″味酸甘,平。″归经:入心、脾、肝、胆经。①《纲目》:"足厥阴、少阳。"②《雷公炮制药性解》:"入心、脾、肝、胆四经。"功能主治:养肝,宁心,安神,敛汗。治虚烦不眠,惊悸怔忡,烦渴,虚汗。①《本经》:"主心腹寒热,邪结气聚,四肢酸疼,湿痹。"②《别录》:″主烦心不得眠,脐上下痛,血转久泄,虚汗烦渴,补中,益肝气,坚筋骨,助阴气,令人肥健。″③《药性论》:″主筋骨风,炒末作汤服之。″④《本草拾遗》:″睡多生使,不得睡炒熟。"⑤王好古:"治胆虚不眠,寒也,炒服;治胆实多睡,热也,生用。"⑥《本草汇言》:"敛气安神,荣筋养髓,和胃运脾。″
泽泻:性味:甘,寒。①《本经》:"味甘,寒。"②《别录》:"咸,无毒。″⑨《药性论》:″味苦。"④《医学启源》:"气平,味甘。″⑤《本草蒙筌》:"甘酸,气寒。"归经:入肾、膀胱经。①《汤液本草》:"入手太阳、少阴经。″②《本草衍义补L遗》:″入足太阳、少阴经。"③《雷公炮制药性解》:″入膀胱、肾、三焦、小肠四经。″④《本草经巯》:"入肾、脾。"功能主治:利水,渗湿,泄热。治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血。(1)利水渗湿:用于水湿内停之尿少、水肿、泻痢及湿热淋浊等证。治胃内停水常配白术。治尿道涩痛、小便不利常配木通、茯苓。
决明子:性味:苦甘,凉。①《本经》:"味咸,平。″②《别录》:″苦甘,微寒,无毒。"③《本草正》:″味微苦微甘,性平,微凉。″归经:入肝、肾经。①《雷公炮制药性解》:"入肝经。"②《本草经疏》:"足厥阴肝,亦入胆、肾。"功能主治:清肝,明目,利水,通便。治风热赤眼,青盲,雀目,高血压,肝炎,肝硬化腹水,习惯性便秘。①《本经):″治青盲,目淫肤赤白膜,眼赤痛,泪出,久服益精光。"②《别录》:″疗唇口青。″③《药性论》:"利五脏,除肝家热。"④《日华子本草》:″助肝气,益精水;调末涂,消肿毒,熁太阳穴治头痛,又贴脑心止鼻衄;作枕胜黑豆,治头风,明目。"⑤《本草衍义补遗》:″解蛇毒。"⑥《生草药性备要》:″治小儿五疳,擦癣癞。"
桔梗:性味:苦辛,平。①《本经》:″辛,微温。″②《别录》:"苦,有小毒。"③《药性论》:"苦,平,无毒。"归经:入肺、胃经。①《汤液本草》:″入足少阴、手太阴。"②《品汇精要》:"行足太阴经。"③《本草经疏》:″入手太阴、少阴,兼入足阳明胃经。"功能主治:开宣肺气,祛痰排脓。治外感咳嗽,咽喉肿痛,肺痈吐脓,胸满胁痛,痢疾腹痛。①《本经》:″主胸胁痛如刀刺,腹满,肠鸣幽幽,惊恐悸气。″②《别录》:″利五脏肠胃,补血气,除寒热、风痹,温中消谷,疗喉咽痛。″③《药性论》:"治下痢,破血,去积气,消积聚,痰涎,主肺热气促嗽逆,除腹中冷痛,主中恶及小儿惊痫。"④《日华子本草》:"下一切气,止霍乱转筋,心腹胀痛,补五劳,养气,除邪辟温,补虚消痰,破症瘕,养血排脓,补内漏及喉痹。"
薄荷:性味:辛,凉。①《医学启源》:″《主治秘要》云,性凉,辛。″②《医林纂要》:"辛,寒。"归经:入肺、肝经。①《汤液本草》:″手大阴、厥阴经药。"②《纲目》:"入手少、太阴,足厥阴。"③《本草新编》:"入肺与包络二经,亦能入肝、胆。″功能主治:疏风,散热,辟秽,解毒。治外感风热,头痛,目赤,咽喉肿痛,食滞气胀,口疮,牙痛,疮疥,瘾疹。①《药性论》:"去愤气,发毒汗,破血止痢,通利关节。″②《千金·食治》:″却肾气,令人口气香洁。主辟邪毒,除劳弊。″③孙思邀:″煎汤洗漆疮。"④《唐本草》:″主贼风,发汗。(治)恶气腹胀满。霍乱。宿食不消,下气。"⑤《食疗本草》:″杵汁服,去心脏风热。″
五味子:性味:酸,温。①《本经》:″味酸,温。"②《别录》:"无毒。"③《唐本草》:"皮肉甘酸,核中辛苦,都有咸味。"④《长沙药解》:″味酸微苦咸,气涩。"归经:入肺、肾经,①《汤液本草》:"入手太阴,足少阴经。"②《纲目》:″入肝、心。″功能主治:敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤赢瘦,梦遗滑精,久泻久痢。①《本经》:"主益气,咳逆上气,劳伤赢度,补不足,强阴,益男子精。"②《别录》:″养五脏,除热,生阴中肌。″③《日华子本草》:″明目,暖水脏,治风,下气,消食,霍乱转筋,痃癖奔豚冷气,消水肿,反胃,心腹气胀,止渴,除烦热,解酒毒,壮筋骨。″④李杲:"生津止渴。治泻痢,补元气不足,收耗散之气,瞳子散大。"⑤王好古:″治喘咳燥嗽,壮水镇阳。"
黄连:性味:苦,寒。归经:归心、脾、胃、肝、胆、大肠经。功能主治:清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。
黄芪:性味:甘,温。归经:归肺、脾经。功能主治:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
夏枯草:性味:辛、苦,寒。归经:归肝、胆经。功能主治:清火,明目,散结,消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,乳痈肿痛;甲状腺肿大,淋巴结结核,乳腺增生,高血压。
鱼腥草:性味:辛,寒。①《别录》:″味辛,微温。″②《履巉岩本草》:"性凉,无毒。"③《滇南本草》:″性寒,味苦辛。″④《纲目》:"辛,微温,有小毒。"⑤《医林纂要》:″甘辛咸。"归经:①《本草经疏》:"入手太阴经。"②《本草再新》:″入肝、肺二经。"功能主治:清热解毒,利尿消肿。治肺炎,肺脓疡,热痢,疟疾,水肿,淋病,白带,痈肿,痔疮,脱肛,湿疹,秃疮,疥癣。①《别录》:″主蠼螋溺疮。"②《日华子本草》:"淡竹筒内煨,敷恶疮白秃。"③《履巉岩本草》:″大治中暑伏热闷乱,不省人事。″④《滇南本草》:"治肺痈咳嗽带脓血,痰有腥臭,大肠热毒,疗痔疮。″⑤《纲目》:″散热毒痈肿,疮痔脱肛,断痁疾,解硇毒。″⑥《医林纂要》:"行水,攻坚,去瘴,解暑。疗蛇虫毒,治脚气,溃痈疽,去瘀血。"⑦陈念祖:"生捣治呕血。″
三七:性味:甘、微苦,温。归经:归肝、胃经。功能主治:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
瓜蒌:性味:甘、微苦、寒。归经:归肺、胃、大肠经。功能主治:清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,乳痈,肺痈,肠痈肿痛,大便秘结。
桂枝:性味:甘、微苦、寒。归经:归肺、胃、大肠经。功能主治:清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,乳痈,肺痈,肠痈肿痛,大便秘结。
白芍:性味:苦酸,凉。①《本经》:"味苦,平。″②《吴普本草》:"桐君:甘,无毒。岐伯:咸。李氏:小寒。雷公:酸。″③《别录》:"酸,平微寒,有小毒。"归经:入肝、脾经。①《品汇精要》:″行手太阴、足太阴经。"②《本草经疏》:"手足太阴引经药,入肝、脾血分。"功能主治:养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下。①《本经》:″主邪气腹痛,除血痹,破坚积,治寒热疝瘕,止痛,利小便,益气。″②《别录》:″通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠,消痈肿,(治)时行寒热,中恶腹痛,腰痛。"③《药性论》:"治肺邪气,腹中疞痛,血气积聚,通宣脏腑拥气,治邪痛败血,主时疾骨热,强五脏,补肾气,治心腹坚胀,妇人血闭不通,消瘀血,能蚀脓。"④《唐本草》:"益女子血。"
车前子:性味:甘,寒。①《本经》:"味甘,寒。"②《别录》:″咸,无毒。"③《药性论》:"甘,平。"④《药品化义》:"味淡,性平。″归经:入肾、膀胱经。①《本草蒙筌》:″入膀胱。″②《雷公炮制药性解》:"入肝、膀胱、小肠三经。"③《本草经疏》:"入肾、肝、膀胱三经。″功能主治:利水,清热,明日,祛痰。治小便不通,淋浊,带下,尿血,暑湿泻痢,咳嗽多痰,湿痹,目赤障翳。①《本经》:″主气癃、止痛,利水道小便,除湿痹。"②《本草经集注》:"主虚劳。"③《别录》:"男子伤中,女子淋沥,不欲食。养肺强阴益精。明目疗赤痛。″④《药性论》:"能去风毒,肝中风热,毒风冲眼目,赤痛障翳,脑痛泪出,去心胸烦热。"⑤《日华子本草》:″通小便淋涩,壮阳。治脱精,心烦。下气。″⑥《医学启源》:"主小便不通,导小肠中热。″⑦《滇南本草》:"消上焦火热,止水泻。"⑧《纲目》:″止暑湿泻痢。"
钩藤:性味:甘,凉。①《别录》:"微寒。″②《药性论》:"味甘,平。"③《蜀本草》:″味苦。″归经:入肝、心经。①《纲目》:″手、足厥阴。″②《本草经疏》:"手少阴、足厥阴经。″功能主治:清热平肝,熄风定惊。治小儿惊痫瘈疭,大人血压偏高,头晕、目眩,妇人子痫。①《别录》:"主小儿寒热,惊痫。"②《药性论》:″主小儿惊啼,瘈疭热壅。″③《日华子本草》:"治客忤胎风。″④《纲目》:"大人头旋目眩,平肝风,除心热,小儿内钓腹痛,发斑疹。″⑤《本草征要》:"舒筋除眩,下气宽中。"
天麻:性味:甘,平。①《本经》:"味辛,温。″②《药性论》:"无毒。味甘,平。"③《医学启源》:"气平,味苦。"归经:入肝经。①《纲目》:″入肝经气分。"②《雷公炮制药性解》:"入肝、膀胱二经。"③《本草新编》:"入脾、肾、肝、胆、心经。″功能主治:息风,定惊。治眩晕眼黑,头风头痛,肢体麻木,半身不遂,语言蹇涩,小儿惊痫动风。①《本经》:″主恶气,久服益气力,长阴肥健。″②《别录》:"消痈肿,下支满,疝,下血。″③《药性论》:"治冷气顽痹,瘫缓不遂,语多恍惚,多惊失志。″④《日华子本草》:″助阳气,补五劳七伤,通血脉,开窍。"⑤《开宝本草》:"主诸风湿痹,四肢拘挛,小儿风痫、惊气,利腰膝,强筋力。"⑥张元素:"治风虚眩晕头痛。″
玫瑰花:性味:甘微苦,温.①姚可成《食物本草》:″味甘微苦,温,无毒。″②《随息居饮食谱》:″甘辛,温。"归经:《本草再新》:"入肝、脾二经。″功能主治:理气解郁,和血散瘀。治肝胃气痛,新久风痹,吐血咯血,月经不调,赤白带下,痢疾,乳痈,肿毒。①姚可成《食物本草》:″主利肺脾,益肝胆,辟邪恶之气,食之芳香甘美,令人神爽。″②《药性考》:″行血破积,损伤瘀痛,浸酒饮。″③《纲目拾遗》:"和血,行血,理气。治风痹。"④《本草再新》:"舒肝胆之郁气,健脾降火。治腹中冷痛,胃脘积寒,兼能破血。″⑤《随息居饮食谱》:″调中活血,舒郁结,辟秽,和肝。酿酒可消乳癖。″⑥《现代实用中药》:″用于妇人月经过多,赤白带下及一般肠炎下痢等。″⑦《山东中药》:″治盱胃气痛,恶心呕吐,消化不良,泄泻,口舌糜破,吐血,噤口痢。″
柴胡:性味:苦,凉。①《本经》:"味苦,平。″②《别录》:″微寒,无毒。"③《日华子本草》:"味甘。"归经:入肝、胆经。①《珍珠囊》:"入足少阳胆、足厥阴肝、手少阳三焦、手厥阴心包络。"②《本草再新》:″入心、肝、脾三经。"功能主治:和解表里,疏肝,升阳。治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂。①《本经》:"主心腹肠胃中结气,饮食积聚,寒热邪气,推陈致新。"②《别录》:"除伤寒心下烦热,诸痰热结实,胸中邪逆,五藏间游气,大肠停积,水胀,及湿痹拘挛。亦可作浴汤。"③《药性论》:"治热劳骨节烦疼,热气,肩背疼痛,宣畅血气,劳乏赢瘦;主下气消食,主时疾内外热不解,单煮服。"④《千金方》:″苗汁治耳聋,灌耳中。″⑤《四声本草》:″主痰澜、胸胁中痞。″
姜黄:性味:辛苦,温。①《唐本草》:"味辛苦,大寒,无毒。″②《本草拾遗》:″味辛,温,无毒。″③李杲:"味苦甘辛,大寒,无毒。″④《东医宝鉴》:"性热,味辛苦,无毒。"归经:入脾、肝经。①《纲目》:"入心、脾。″②《雷公炮制药性解》:"入心、肺二经。"③《本草经疏》:"入足太阴、厥阴。″功能主治:破血,行气,通经,止痛。治心腹痞满胀痛,臂痛,症瘕,妇女血瘀经闭,产后瘀停腹痛,跌扑损伤,痈肿。用于气滞血瘀的胸腹痛、痛经及肢体疼痛,常配元胡、香附。①《唐本草》:″主心腹结积,疰忤,下气,破血,除风热,消痈肿。功力烈于郁金。″②《日华子本草》:"治症瘕血块,痈肿,通月经,治跌扑瘀血,消肿毒;止暴风痛冷气,下食。"③《本草图经》:"治气胀及产后败血攻心。"
薤白:性味:辛苦,温。①《木经》:″味辛,温。″②《别录》:″苦,温,无毒。″③《千金·食治》:″味苦辛,温,滑,无毒。"④《医林纂要》:
"甘酸辛,温。"归经:①《汤液本草》:″入手阳明经。"②《本草经解》:"入足厥阴肝经、手太阴肺经、手少阴心经。"功能主治:理气,宽胸,通阳,散结。治胸痹心痛彻背,脘痞不舒,干呕,泻痢后重,疮疖。①《本经》:"主金疮疮败。″②《别录》:"归于骨。除寒热,去水气,温中散结。诸疮中风寒水肿,以涂之。″③《千金·食治》:"能生肌肉,利产妇。骨鲠在咽不下者,食之则去。"④唐本草》:″白者补而美,赤者主金疮及凤。"⑤《食疗本草》:"治妇人赤白带下。"⑥《本草拾遗》:"调中,主久利不瘥,大腹内常恶者,但多煮食之。″⑦《本草图经》:"补虚,解毒。″″主脚气;煮与蓐妇饮之,易产。″
熟地黄:性味:甘,微温。归经:归肝、肾经。功能主治:滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。
地龙:性味:甘,微温。归经:归肝、肾经。功能主治:滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。
鸡血藤:性味:苦甘,温。①《饮片新参》:"苦涩香微甘。″②《本草正义》:"温。"③江西《中草药学》:″苦温微甘。"归经:《本草再新》:"入心、脾二经。"功能主治:活血、舒筋。治腰膝酸痛,麻木瘫痪,月经不调。①《纲目拾遗》:"活血,暖腰膝,已风瘫。″②《本草再新》:"补中燥胃。"③《饮片新参》:"去瘀血,生新血,流利经脉。治暑痧,风血痹症。"④《现代实用中药》:″为强壮性之补血药,适用于贫血性之神经麻痹症,如肢体及腰膝酸痛,麻木不仁等。又用于妇女月经不调,月经闭止等,有活血镇痛之效。"
桃仁:性味:苦甘,平。①《本经》:″味苦,平。″②《别录》:″甘,无毒。″③《千金·食治》:"味苦甘辛,平,无毒。″归经:入心、肝、大肠经。①《汤液本草》:″入手、足厥阴经。"②《雷公炮制药性解》:″入肝、大肠二经。″③《本草经解》:″入手太阴肺经,手少阴心经,足太阴脾经。"功能主治:破血行瘀,润燥滑肠。治经闭,症瘕,热病蓄血,风痹,疟疾,跌打损伤,瘀血肿痛,血燥便秘。①《本经》:"主瘀血,血闭症瘕,邪气,杀小虫。"②《别录》:″止咳逆上气,消心下坚,除卒暴击血,破症瘕,通脉,止痛。″③孟诜:″杀三虫,止心痛。″④《医学启源》:″治大便血结。"
徐长卿:性味:辛,温。①《本经》:″味辛,温。″②《别录》:"无毒。"功能主治:镇痛,止咳,利水消肿,活血解毒。治胃痛,牙痛,风湿疼痛,经期腹痛,慢性气管炎,腹水,水肿,痢疾,肠炎,跌打损伤,湿疹,荨麻疹,毒蛇咬伤。1、用于风湿痹痛、腰痛、跌打损伤疼痛、脘腹痛、牙痛等各种痛症。徐长卿有较好的祛风止痛作用,广泛地用于风湿、寒凝、气滞、血瘀所致的各种痛症。近年来也用于手术后疼痛及癌肿疼痛,有一定的止痛作用。可单味应用,或随证配伍有关的药物。2、用湿疹、风疹块、顽癣等皮肤病。本品有祛风止痒作用。可单用内服或煎汤外洗,亦可配伍苦参、地肤子、白鲜皮等清利湿热的药物。此外,本品还能解蛇毒,治毒蛇咬伤。可与半边莲同用内服或外用。
红景天:性味:寒;甘;涩。归经:肺经。功能主治:补气清肺;益智养心;收涩止血;散瘀消肿。主气虚体弱;病后畏寒;气短乏力;肺热咳嗽;咯血;白带腹泻;跌打损伤;烫火伤;神经症;高原反应。
葛根:性味:甘辛,平。①《本经》:"味甘,平。"②《别录》:"无毒。生根汁,大寒。"③《纲目》:"甘辛,平,无毒。"归经:入脾、胃经。①张元素:″通行足阳明经。"②《本草新编》:″入胃,又入肺。″③《本草求真》:″入胃,兼入脾。″④《要药分剂》:″入胃、膀胱二经,兼入脾经。″功能主治:升阳解肌,透疹止泻,除烦止温。治伤寒、温热头痛项强,烦热消渴,泄泻,痢疾,癍疹不透,高血压,心绞痛,耳聋。①《本经》:"主消渴,身太热,呕吐,诸痹,起阴气,解诸毒。"②《别录》:"疗伤寒中风头痛,解肌,发表,出汗,开腠理。疗金疮,止痛,胁风痛。″″生根汁,疗消渴,伤寒壮热。″③《本草经集注》:"杀野葛、巴豆、百药毒。"④陶弘景:"生者捣取汁饮之,解温病发热。葛根为屑,疗金疮断血,亦疗疟及疮。″⑤《药性论》:"治天行上气,呕逆,开胃下食,主解酒毒,止烦渴。熬屑治金疮,治时疾解热。"⑥《唐本草》:″末服之,主猘狗啮,并饮其汁良。"
石菖蒲:性味:辛,微温,①《本经》:″辛,温。″②《另口录》:"无毒。″③《药性论》:″味苦辛,无毒。"归经:入口、肝、脾经。①《纲目》:″手少阴、足厥阴。"②《雷公炮制药性解》:"入心、脾、膀胱三经。"③《本草经解》:"入足厥阴肝经、手太阴肺经。"功能主治:开窍,豁痰,理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥、噤口下痢、神昏癫痫、健忘耳聋。①《本经》:″主风寒湿痹,咳逆上气,开心孔,补五脏,通九窍,明耳目,出音声。"②《别录》:"主耳聋,痈疮,温肠胃,止小便利,四肢湿痹,不得屈伸,小儿温疟,身积热不解,可作浴汤。聪耳目,益心智。"③《药性论》:"治风湿顽痹,耳鸣,头风,泪下,杀诸虫,治恶疮疥瘙。″
半夏:性味:辛,温;有毒。归经:归脾、胃、肺经。功能主治:燥湿化痰,降逆止呕,消痞散结。用于痰多咳喘,痰饮眩悸,风痰眩晕,痰厥头痛,呕吐反胃,胸脘痞闷,梅核气;生用外治痈肿痰核。姜半夏多用于降逆止呕。
下面结合具体实施例对本发明做进一步阐述。
实施例1
绞股蓝2份、甘草2份、茯苓3份、枸杞8份、益母草9份、丹参1份、川穹2份、酸枣仁3份、泽泻3份、决明子4份、桔梗5份、薄荷2份、五味子2份、黄连3份、黄芪2份、夏枯草2份、鱼腥草1份、三七3份、瓜蒌6份、桂枝4份、白芍7份、车前子2份、钩藤1份、天麻2份、玫瑰花3份、柴胡6份、姜黄3份、薤白4份、熟地黄5份、地龙2份、鸡血藤2份、桃仁3份、徐长卿3份、红景天2份、葛根4份、石菖蒲3份、半夏6份、金银花4份、凌霄花6份、白薇4份。
所述制剂剂型为口服液剂,其制备方法的包括:
a、取原料加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-180目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分1;
b、将乙醇提取过的药渣放入10倍量水中,加热回流提取2次,每次提取时间为1~2小时,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分2;
c、将上述两种组分膏状浓缩成糊状,浓缩液用CO60灭菌,辐照剂量8k,加入糊精,然后真空罐装密封即得,使用时直接饮用。
实施例2
a、取原料药绞股蓝2份、甘草2份、茯苓3份、枸杞8份、益母草9份、丹参1份、川穹2份、酸枣仁3份、泽泻3份、决明子4份、桔梗5份、薄荷2份、五味子2份、黄连3份、黄芪2份、夏枯草2份、鱼腥草1份、三七3份、瓜蒌6份、桂枝4份、白芍7份、车前子2份、钩藤1份、天麻2份、玫瑰花3份、柴胡6份、姜黄3份、薤白4份、熟地黄5份、地龙2份、鸡血藤2份、桃仁3份、徐长卿3份、红景天2份、葛根4份、石菖蒲3份、半夏6份、金银花4份、凌霄花6份、白薇3份入水中浸泡,热提取2次,成浸膏状,为组分1;
b、药渣乙醇提取1次,浓缩过滤为浸膏状,为组分2;
c、将上述两种浸膏浓缩成糊状,浓缩液用CO60灭菌,辐照剂量8k,加入糊精,然后真空冷冻密封即得。
实施例3
绞股蓝1份、甘草10份、茯苓3份、枸杞10份、益母草4份、丹参1份、川穹2份、酸枣仁5份、泽泻4份、决明子5份、桔梗5份、薄荷2份、五味子3份、黄连6份、黄芪3份、夏枯草2份、鱼腥草1份、三七3份、瓜蒌7份、桂枝4份、白芍7份、车前子2份、钩藤1份、天麻2份、玫瑰花3份、柴胡6份、姜黄3份、薤白4份、熟地黄5份、地龙2份、鸡血藤2份、桃仁3份、徐长卿3份、红景天2份、葛根4份、石菖蒲3份、半夏6份、金银花4份、凌霄花2份、白薇1份。
所述制剂剂型为口服液剂,其制备方法的包括:
a、取原料加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-180目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分1;
b、将乙醇提取过的药渣放入10倍量水中,加热回流提取2次,每次提取时间为1~2小时,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分2;
c、将上述两种组分膏状浓缩成糊状,浓缩液用CO60灭菌,辐照剂量8k,加入糊精,然后真空罐装密封即得,使用时直接饮用。
药理学毒性试验
1、急性毒性试验
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的中药制剂胶囊剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药制剂胶囊剂的最大给药量为488.8g生药/kg/d(LD50>488.8g生药/kg)。本发明的中药制剂每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药制剂的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。
2、长期毒性试验
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂胶囊剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明的中药制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。
临床试验
一般资料
为了验证本发明中药组合物的效果,在青岛市多名血管外科专家的共同研究和指导下,自2008年3月至2015年11月,收治早期闭塞性周围动脉粥样硬化患者237例。全部病例均经体检,检查足背动脉搏动的强度、指压甲床试验、测踝动脉收缩压与肱动脉收缩压比值及实验室辅助检查等多项检查确诊,且无严重心、肝、肾功能不良。随机分为治疗组121例,其中年龄20~65岁,平均年龄54岁。对照组116例,其中年龄30~71岁,平均年龄55岁。两组在性别、年龄、病情等方面均无显著差异(P>0.05),具有可比性,详见表1。
注:两组比较:P>0.05
诊断标准:
本发明参照王吉耀主编的供8年制及7年制临床医学等专业用的内科学367页之诊断标准制定。①年龄多在50岁以上;②有高脂血症、糖尿病或高血压病史;③间歇性跛行,肢痛伴下肢动脉搏动减弱、消失、不对称,踝/肱动脉收缩压指数<1.0;④多普勒检查阳性。
治疗方法:
对照组:采用西药常规治疗:控制血脂用辛伐他汀或非诺贝特,控制血糖用格列吡嗪或胰岛素,控制血压用依那普利、硝苯地平缓释片,改善患者血液循环用低分子右旋糖酐,其它采取对症治疗。
治疗组:服用本发明实施例3药物,每天分三次饭后口服,10天为一疗程。两组分别治疗10周后,观察临床症状与各项辅助检查等改善情况。
疗效评价:
显效:临床症状消失,指压甲床毛细血管充盈时间缩短,测踝/肱指数接近或等于1;足背动脉搏动接近正常或正常;血脂血压血糖控制正常。
有效:临床症状基本消失,指压甲床毛细血管充盈时间稍延长或接近正常,测踝/肱指数大于0.7以上;足背动脉搏动接近正常;血脂血压血糖均控制在接近正常。
无效:临床症状与指压甲床毛细血管充盈时间均无明显改善,测踝/肱指数在0.5以下;足背动脉搏动减弱或消失。
统计学方法:数据用率表示,采用X2检验,以P<0.05为差异有统计学意义。
结果:
治疗前后两组症状改善情况比较
治疗组服用本发明实施例3中药组合物,临床症状改善率(92.6%)显著优于对照组单纯用西药常规治疗后临床症状改善率(43.8%),详见表2。
治疗前后两组辅助检查结果改善比较:详见表3
注:两组比较:P>0.05
不良反应:对照组有13例出现干咳,有4例出现低血糖眩晕。治疗组未见明显不良反应。
以上数据显著说明了本发明各原料有效成份相互影响、协同作用,对动脉粥样硬化患者有很好的治疗效果。以上所述,仅是本发明的最佳实施例而已,并非对本发明作任何形式上的限制,任何熟悉本领域的技术人员,在不脱离本发明技术方案范围情况下,利用上述揭示的方法内容对本发明技术方案做出许多可能的变动和修饰,均属于权利要求书保护的范围。
Claims (10)
1.一种治疗动脉粥样硬化的中药制剂,其特征在于:由以下各组分组成:
绞股蓝1-30份、甘草1-30份、茯苓1-30份、枸杞1-30份、益母草1-30份、丹参1-30份、川穹1-30份、酸枣仁1-30份、泽泻1-30份、决明子1-30份、桔梗1-30份、薄荷1-30份、五味子1-30份、黄连1-30份、黄芪1-30份、夏枯草1-30份、鱼腥草1-30份、三七1-30份、瓜蒌1-30份、桂枝1-30份、白芍1-30份、车前子1-30份、钩藤1-30份、天麻1-30份、玫瑰花1-30份、柴胡1-30份、姜黄1-30份、薤白1-30份、熟地黄1-30份、地龙1-30份、鸡血藤1-30份、桃仁1-30份、徐长卿1-30份、红景天1-30份、葛根1-30份、石菖蒲1-30份、半夏1-30份、金银花1-30份、凌霄花1-30份、白薇1-30份。
2.根据权利要求1所述的一种治疗动脉粥样硬化的中药制剂,其特征在于:由以下重量份数的各组分组成:
绞股蓝1-20份、甘草1-20份、茯苓1-20份、枸杞1-20份、益母草1-20份、丹参1-20份、川穹1-20份、酸枣仁1-20份、泽泻1-20份、决明子1-20份、桔梗1-20份、薄荷1-20份、五味子1-20份、黄连1-20份、黄芪1-20份、夏枯草1-20份、鱼腥草1-20份、三七1-20份、瓜蒌1-20份、桂枝1-20份、白芍1-20份、车前子1-20份、钩藤1-20份、天麻1-20份、玫瑰花1-20份、柴胡1-20份、姜黄1-20份、薤白1-20份、熟地黄1-20份、地龙1-20份、鸡血藤1-20份、桃仁1-20份、徐长卿1-20份、红景天1-20份、葛根1-20份、石菖蒲1-20份、半夏1-20份、金银花1-20份、凌霄花1-20份、白薇1-20份。
3.根据权利要求1至2所述的一种治疗动脉粥样硬化的中药制剂,其特征在于:由以下重量份数的各组分组成:
绞股蓝1-10份、甘草1-10份、茯苓1-10份、枸杞1-10份、益母草1-10份、丹参1-10份、川穹1-10份、酸枣仁1-10份、泽泻1-10份、决明子1-10份、桔梗1-10份、薄荷1-10份、五味子1-10份、黄连1-10份、黄芪1-10份、夏枯草1-10份、鱼腥草1-10份、三七1-10份、瓜蒌1-10份、桂枝1-10份、白芍1-10份、车前子1-10份、钩藤1-10份、天麻1-10份、玫瑰花1-10份、柴胡1-10份、姜黄1-10份、薤白1-10份、熟地黄1-10份、地龙1-10份、鸡血藤1-10份、桃仁1-10份、徐长卿1-10份、红景天1-10份、葛根1-10份、石菖蒲1-10份、半夏1-10份、金银花1-10份、凌霄花1-10份、白薇1-10份。
4.根据权利要求1至3所述的一种治疗动脉粥样硬化的中药制剂,其特征在于:所述中药制剂的剂型为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、蜜丸剂、散剂、丹剂、溶液剂、注射剂、栓剂、硬膏剂或糖浆剂。
5.根据权利要求1至4所述的一种治疗动脉粥样硬化的中药制剂的制备方法,其特征在于:所述制剂剂型为口服液剂,其制备方法的包括:
a、取原料放入乙醇中浸泡,热提取2次,成膏状,为组分1;
b、药渣水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状浓缩成糊状,灭菌,加入糊精,然后真空冷冻密封。
6.根据权利要求5所述的一种治疗动脉粥样硬化的中药制剂的制备方法,其特征在于:所述步骤a中,取原料加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-180目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分1。。
7.根据权利要求5所述的一种治疗动脉粥样硬化的中药制剂的制备方法,其特征在于:所述步骤b中,将乙醇提取过的药渣放入10倍量水中,加热回流提取2次,每次提取时间为1~2小时,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.10的浸膏,加热浓缩至膏状,静置备用,成为组分2。
8.根据权利要求5所述的一种治疗动脉粥样硬化的中药制剂的制备方法,其特征在于:所述步骤c中,将上述两种组分膏状浓缩成糊状,浓缩液用CO60灭菌,辐照剂量8k,加入糊精,然后真空罐装密封即得,使用时直接饮用。
9.一种如权利要求1至8所述的治疗动脉粥样硬化的中药制剂的制备方法,其特征在于,所述制剂剂型为胶囊剂,其制备方法的包括:
a.将所述原料放入粉碎机粉碎后过筛;
b.将过筛后剩下的颗粒物放入乙醇中加热回流提取2次;
c.再取上述乙醇提取后的药渣,加水加热回流提取1次;
d.将上述两种提取液合并,减压回收乙醇并喷雾干燥,得药粉;混合过筛得到的药粉装入胶囊制为胶囊剂。
10.一种如权利要求1至9所述的治疗动脉粥样硬化的中药制剂的制备方法,其特征在于,所述内服药物的剂型为丸剂,其制备步骤包括:
a.将所述原料药混合,切碎,过120目筛,得细药粉备用;
b.将未过筛的粗粉浸泡乙醇中提取2次;
c.再取上述步骤提取后的药渣,加水加热回流提取2次;
d.将上述两种提取液合并,减压回收乙醇成浸膏,与a步骤得到细药粉合并加入蜂蜜搓成丸剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610052679.8A CN105497816A (zh) | 2016-01-20 | 2016-01-20 | 一种治疗动脉粥样硬化的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610052679.8A CN105497816A (zh) | 2016-01-20 | 2016-01-20 | 一种治疗动脉粥样硬化的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105497816A true CN105497816A (zh) | 2016-04-20 |
Family
ID=55706368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610052679.8A Withdrawn CN105497816A (zh) | 2016-01-20 | 2016-01-20 | 一种治疗动脉粥样硬化的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105497816A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106166251A (zh) * | 2016-08-08 | 2016-11-30 | 青岛友诚高新技术有限公司 | 一种用于治疗哮喘的中药制剂及其制备方法 |
CN109007483A (zh) * | 2017-11-16 | 2018-12-18 | 阿卜杜米吉提·阿卜力孜 | 辅助治疗高血压及高血脂的山楂果醋饮料及其制备方法 |
CN113694136A (zh) * | 2021-09-01 | 2021-11-26 | 马万凯 | 一种治疗心脑血管病的中药及制备方法 |
CN116650606A (zh) * | 2023-07-06 | 2023-08-29 | 湖南中医药大学 | 一种用于防治动脉粥样硬化的药物组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007234A (zh) * | 2012-12-28 | 2013-04-03 | 青岛华仁信息技术开发有限公司 | 一种治疗子宫内膜异位引起痛经的中药制剂及其制备方法 |
CN104435449A (zh) * | 2014-12-23 | 2015-03-25 | 青岛市市立医院 | 一种抗动脉粥样硬化的药物组合物及其应用 |
CN104645244A (zh) * | 2015-03-14 | 2015-05-27 | 朱延朋 | 一种治疗动脉硬化症的中药组合物 |
CN104940846A (zh) * | 2015-07-21 | 2015-09-30 | 相宏杰 | 一种用于治疗动脉粥样硬化的中药组合物 |
-
2016
- 2016-01-20 CN CN201610052679.8A patent/CN105497816A/zh not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007234A (zh) * | 2012-12-28 | 2013-04-03 | 青岛华仁信息技术开发有限公司 | 一种治疗子宫内膜异位引起痛经的中药制剂及其制备方法 |
CN104435449A (zh) * | 2014-12-23 | 2015-03-25 | 青岛市市立医院 | 一种抗动脉粥样硬化的药物组合物及其应用 |
CN104645244A (zh) * | 2015-03-14 | 2015-05-27 | 朱延朋 | 一种治疗动脉硬化症的中药组合物 |
CN104940846A (zh) * | 2015-07-21 | 2015-09-30 | 相宏杰 | 一种用于治疗动脉粥样硬化的中药组合物 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106166251A (zh) * | 2016-08-08 | 2016-11-30 | 青岛友诚高新技术有限公司 | 一种用于治疗哮喘的中药制剂及其制备方法 |
CN109007483A (zh) * | 2017-11-16 | 2018-12-18 | 阿卜杜米吉提·阿卜力孜 | 辅助治疗高血压及高血脂的山楂果醋饮料及其制备方法 |
CN113694136A (zh) * | 2021-09-01 | 2021-11-26 | 马万凯 | 一种治疗心脑血管病的中药及制备方法 |
CN113694136B (zh) * | 2021-09-01 | 2022-04-15 | 马万凯 | 一种治疗心脑血管病的中药及制备方法 |
CN116650606A (zh) * | 2023-07-06 | 2023-08-29 | 湖南中医药大学 | 一种用于防治动脉粥样硬化的药物组合物 |
CN116650606B (zh) * | 2023-07-06 | 2024-05-03 | 湖南中医药大学 | 一种用于防治动脉粥样硬化的药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN103007234A (zh) | 一种治疗子宫内膜异位引起痛经的中药制剂及其制备方法 | |
CN103520621B (zh) | 一种治疗老年性白内障的中药组合物及其制备方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN102205108A (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
CN103751716A (zh) | 一种治疗肾结石和胆结石的药物组合物 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN103690784A (zh) | 治疗糖尿病肾病合并高血压肾病的中药组合物及制备方法 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN103041262A (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
CN103301341A (zh) | 一种治疗缺血性脑中风的中药组合物 | |
CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN103417836B (zh) | 治疗肿瘤的中药组合物及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN105311527A (zh) | 一种用于治疗子宫内膜移位症的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160420 |